262 related articles for article (PubMed ID: 32987711)
1. Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer.
Ratajczak-Wielgomas K; Kmiecik A; Grzegrzołka J; Piotrowska A; Gomulkiewicz A; Partynska A; Pawelczyk K; Nowinska K; Podhorska-Okolow M; Dziegiel P
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987711
[TBL] [Abstract][Full Text] [Related]
2. Role of Periostin Expression in Non-Small Cell Lung Cancer: Periostin Silencing Inhibits the Migration and Invasion of Lung Cancer Cells via Regulation of MMP-2 Expression.
Ratajczak-Wielgomas K; Kmiecik A; Dziegiel P
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163164
[TBL] [Abstract][Full Text] [Related]
3. Periostin expression in cancer-associated fibroblasts of invasive ductal breast carcinoma.
Ratajczak-Wielgomas K; Grzegrzolka J; Piotrowska A; Gomulkiewicz A; Witkiewicz W; Dziegiel P
Oncol Rep; 2016 Nov; 36(5):2745-2754. PubMed ID: 27633896
[TBL] [Abstract][Full Text] [Related]
4. Single-cell and spatial transcriptomics reveal POSTN
Chen C; Guo Q; Liu Y; Hou Q; Liao M; Guo Y; Zang Y; Wang F; Liu H; Luan X; Liang Y; Guan Z; Li Y; Liu H; Dong X; Zhang X; Liu J; Xu Q
Clin Transl Med; 2023 Dec; 13(12):e1515. PubMed ID: 38115703
[TBL] [Abstract][Full Text] [Related]
5. Characterization of periostin isoform pattern in non-small cell lung cancer.
Morra L; Rechsteiner M; Casagrande S; von Teichman A; Schraml P; Moch H; Soltermann A
Lung Cancer; 2012 May; 76(2):183-90. PubMed ID: 22079858
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.
Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y
Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072
[TBL] [Abstract][Full Text] [Related]
7. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer.
Takatsu F; Suzawa K; Tomida S; Thu YM; Sakaguchi M; Toji T; Ohki M; Tsudaka S; Date K; Matsuda N; Iwata K; Zhu Y; Nakata K; Shien K; Yamamoto H; Nakayama A; Okazaki M; Sugimoto S; Toyooka S
J Mol Med (Berl); 2023 Dec; 101(12):1603-1614. PubMed ID: 37831111
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.
Schulze AB; Schmidt LH; Heitkötter B; Huss S; Mohr M; Marra A; Hillejan L; Görlich D; Barth PJ; Rehkämper J; Evers G
Thorac Cancer; 2020 Jan; 11(1):120-129. PubMed ID: 31760702
[TBL] [Abstract][Full Text] [Related]
9. Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).
Hötzel J; Melling N; Müller J; Polonski A; Wolters-Eisfeld G; Izbicki JR; Karstens KF; Tachezy M
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2285-2292. PubMed ID: 31372722
[TBL] [Abstract][Full Text] [Related]
10. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
[TBL] [Abstract][Full Text] [Related]
11. Single-cell Transcriptomic Analysis Reveals an Immunosuppressive Network Between POSTN CAFs and ACKR1 ECs in TKI-resistant Lung Cancer.
Wang Z; Yan N; Sheng H; Xiao Y; Sun J; Cao C
Cancer Genomics Proteomics; 2024; 21(1):65-78. PubMed ID: 38151287
[TBL] [Abstract][Full Text] [Related]
12. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
[TBL] [Abstract][Full Text] [Related]
13. Exploring the association of POSTN
Lin S; Zhou M; Cheng L; Shuai Z; Zhao M; Jie R; Wan Q; Peng F; Ding S
Int J Biol Macromol; 2024 May; 268(Pt 1):131560. PubMed ID: 38631570
[TBL] [Abstract][Full Text] [Related]
14. CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
Edlund K; Lindskog C; Saito A; Berglund A; Pontén F; Göransson-Kultima H; Isaksson A; Jirström K; Planck M; Johansson L; Lambe M; Holmberg L; Nyberg F; Ekman S; Bergqvist M; Landelius P; Lamberg K; Botling J; Ostman A; Micke P
Int J Cancer; 2012 Nov; 131(10):2264-73. PubMed ID: 22392539
[TBL] [Abstract][Full Text] [Related]
15. Expression of Periostin in Cancer-associated Fibroblasts in Mammary Cancer in Female Dogs.
Borecka P; Ratajczak-Wielgomas K; Ciaputa R; Kandefer-Gola M; Janus I; Piotrowska A; Kmiecik A; Podhorska-Okolów M; Dzięgiel P; Nowak M
In Vivo; 2020; 34(3):1017-1026. PubMed ID: 32354887
[TBL] [Abstract][Full Text] [Related]
16. Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma.
Jang SH; Oh MH; Cho H; Lee JH; Lee H; Ahn H; Kim H
Pol J Pathol; 2019; 70(3):189-197. PubMed ID: 31820862
[TBL] [Abstract][Full Text] [Related]
17. Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients.
Ma H; Wang L; Zhang T; Shen H; Du J
Tumour Biol; 2016 Jan; 37(1):1341-7. PubMed ID: 26293896
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.
Hao J; Zeltz C; Pintilie M; Li Q; Sakashita S; Wang T; Cabanero M; Martins-Filho SN; Wang DY; Pasko E; Venkat K; Joseph J; Raghavan V; Zhu CQ; Wang YH; Moghal N; Tsao MS; Navab R
Neoplasia; 2019 May; 21(5):482-493. PubMed ID: 30978569
[TBL] [Abstract][Full Text] [Related]
19. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of CD44s expression in resected non-small cell lung cancer.
Ko YH; Won HS; Jeon EK; Hong SH; Roh SY; Hong YS; Byun JH; Jung CK; Kang JH
BMC Cancer; 2011 Aug; 11():340. PubMed ID: 21819617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
